(S (S (VP (VBG Identifying) (NP (NP (NN patient) (NNS characteristics)) (SBAR (WHNP (WDT that)) (S (VP (VBP influence) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (JJ colorectal) (JJ polyp) (NN recurrence)))))))))) (VP (MD can) (VP (VB provide) (NP (NP (JJ important) (NNS insights)) (PP (IN into) (SBAR (WHNP (WDT which) (NNS patients)) (S (VP (VBP are) (PP (IN at) (NP (NP (JJR higher) (NN risk)) (PP (IN for) (NP (NN recurrence)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD used) (NP (JJ natural) (NN language) (NN processing)) (S (VP (TO to) (VP (VB extract) (NP (JJ polyp) (JJ morphological) (NNS characteristics)) (PP (IN from) (NP (NP (CD 953) (JJ polyp-presenting) (NNS patients) (POS â€º)) (JJ electronic) (JJ medical) (NNS records))))))) (. .))
(S (NP (PRP We)) (VP (VBD used) (NP (JJ subsequent) (NN colonoscopy) (NNS reports)) (S (VP (TO to) (VP (VB examine) (SBAR (WHADVP (WRB how)) (S (NP (NP (NP (DT the) (NN time)) (PP (TO to) (NP (VB polyp) (NN recurrence)))) (PRN (-LRB- -LRB-) (S (NP (CD 731) (NNS patients)) (VP (JJ experienced) (NP (NN recurrence)))) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN influenced) (PP (IN by) (NP (NP (DT these) (NNS characteristics)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ anthropometric) (NNS features)))) (S (VP (VBG using) (NP (NP (NNP Kaplan-Meier) (NNS curves)) (, ,) (NP (NNP Cox) (JJ proportional) (NNS hazards) (NN modeling)) (, ,) (CC and) (NP (JJ random) (NN survival) (JJS forest) (NNS models))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN recurrence)))) (VP (VBN differed) (ADVP (RB significantly)) (PP (IN by) (NP (NP (NN polyp) (NN size) (, ,) (NN number) (, ,) (CC and) (NN location)) (CC and) (NP (JJ patient) (NN smoking) (NN status)))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP (JJ right-sided) (NN colon) (NNS polyps)) (VP (VBD increased) (NP (NN recurrence) (NN risk)) (PP (IN by) (NP (CD 30) (NN %))) (PP (VBN compared) (PP (TO to) (NP (JJ left-sided) (NNS polyps))))) (. .))
(S (NP (NP (NN History)) (PP (IN of) (NP (NN tobacco) (NN use)))) (VP (VBD increased) (NP (JJ polyp) (NN recurrence) (NN risk)) (PP (IN by) (NP (CD 20) (NN %))) (PP (VBN compared) (PP (TO to) (NP (NNS never-users))))) (. .))
(S (NP (DT A) (NN random) (NN survival) (JJS forest) (NN model)) (VP (VP (VBD showed) (NP (NP (DT an) (NNP AUC)) (PP (IN of) (NP (CD 0.65))))) (CC and) (VP (VBD identified) (NP (NP (JJ several) (JJ other) (JJ predictive) (NNS variables)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB inform) (NP (NP (NN development)) (PP (IN of) (NP (JJ personalized) (NN polyp) (NN surveillance) (NNS plans))))))))))) (. .))
